EQ

1.0605.36%
BS

Bruce Steel

Co-Founder, CEO & Director

Mr. Bruce Steel serves as Strategic Advisory Board at CR Group L.P. Mr. Steel is a co-founder, Chief Executive Officer of Equillium, Inc. since January 1, 2020 and serves as its Director since March 2017. He serves as Director of Breathe Technologies, Inc. Mr. Steel was President of Equillium, Inc. from June 01, 2018 until October 01, 2025. He was Chief Business Officer of Equillium, Inc. from June 01, 2018 to January 1, 2020. He served as a Director at AEGEA Medical Inc., until 2020. He served as Chairman of Board of Directors of Zosano Pharma Corporation from 2012 to 2017. He served as a Board Observer at TRACON Pharmaceuticals, Inc. since September 22, 2014. He served as a Director of Zosano, Inc. from October 31, 2013 to April 7, 2014. He has been a Managing Director at BioMed Ventures LP since September 2010. Mr. Steel founded BioMed Ventures since 2010. He directed investments in several biotechnology companies. Mr. Steel focuses on Venture Capital. He was an officer on the executive team of BioMed Realty Trust Inc. From 2008 to 2010, Mr. Steel served as the Chief Business Officer at Anaphore, Inc. He served as Chief Business Officer of RuiYi Inc. He was Co-Founder of Rincon Pharmaceuticals, Inc. from 2005 until 2008 and served as its Chief Executive Officer from 2005 until 2008. Mr. Steel served as Chairman of Board of Directors of Rincon Pharmaceuticals Inc. He served as the Head of Corporate Development at Ambit Biosciences from 2002 to 2005. Prior to Ambit, Mr. Steel directed corporate development at Akesis Pharmaceuticals. He holds the designation of Chartered Financial Analyst. Mr. Steel received his Bachelor of Arts degree from Dartmouth College in 1988, his Master of Business Administration degree from the Marshall School of Business at the University of Southern California in 1995.

Positions